|
1
|
Cho KR and Vogelstein B: Genetic
alterations in the adenoma-carcinoma sequence. Cancer. 70 6
Suppl:S1727–S1731. 1992. View Article : Google Scholar
|
|
2
|
Tatsumi N, Kushima R, Vieth M, Mukaisho K,
Kakinoki R, Okabe H, Borchard F, Stolte M, Okanoue T and Hattori T:
Cytokeratin 7/20 and mucin core protein expression in ulcerative
colitis-associated colorectal neoplasms. Virchows Arch.
448:756–762. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stenling R, Lindberg J, Rutegård J and
Palmqvist R: Altered expression of CK7 and CK20 in preneoplastic
and neoplastic lesions in ulcerative colitis. APMIS. 115:1219–1226.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baytner S, Mitmaker B, Gordon PH and Wang
E: Immunohistochemical expression of mutant p53 oncogene in
transitional mucosa adjacent to human colon cancer. Clin Invest
Med. 16:379–385. 1993.PubMed/NCBI
|
|
5
|
Jothy S, Ślesak B, Harłozińska A, Lapińska
J, Adarniak J and Rabczyński J: Field effect of human colon
carcinoma on normal mucosa: Relevance of carcinoembryonic antigen
expression. Tumour Biol. 17:58–64. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen L, Kondo Y, Rosner GL, Xiao L,
Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR,
Einspahr JG, et al: MGMT promoter methylation and field defect in
sporadic colorectal cancer. J Natl Cancer Inst. 97:1330–1338. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hawthorn L, Lan L and Mojica W: Evidence
for field effect cancerization in colorectal cancer. Genomics.
103:211–221. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sanz-Pamplona R, Berenguer A, Cordero D,
Molleví DG, Crous-Bou M, Sole X, Paré-Brunet L, Guino E, Salazar R,
Santos C, et al: Aberrant gene expression in mucosa adjacent to
tumor reveals a molecular crosstalk in colon cancer. Mol Cancer.
13:462014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bayrak R, Yenidünya S and Haltas H:
Cytokeratin 7 and cytokeratin 20 expression in colorectal
adenocarcinomas. Pathol Res Pract. 207:156–160. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moll R, Franke WW, Schiller DL, Geiger B
and Krepler R: The catalog of human cytokeratins: Patterns of
expression in normal epithelia, tumors and cultured cells. Cell.
31:11–24. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ramaekers F, van Niekerk C, Poels L,
Schaafsma E, Huijsmans A, Robben H, Schaart G and Vooijs P: Use of
Monoclonal antibodies to keratin 7 in the differential diagnosis of
adenocarcinomas. Am J Pathol. 136:641–655. 1990.PubMed/NCBI
|
|
12
|
Wang C, Curtis JE, Geissler EN, McCulloch
EA and Minden MD: The expression of the proto-oncogene C-kit in the
blast cells of acute myeloblastic leukemia. Leukemia. 3:699–702.
1989.PubMed/NCBI
|
|
13
|
Ikeda H, Kanakura Y, Tamaki T, Kuriu A,
Kitayama H, Ishikawa J, Kanayama Y, Yonezawa T, Tarui S and Griffin
JD: Expression and functional role of the proto-oncogene c-kit in
acute myeloblastic leukemia cells. Blood. 78:2962–2968.
1991.PubMed/NCBI
|
|
14
|
Natali PG, Nicotra MR, Winkler AB,
Cavaliere R, Bigotti A and Ullrich A: Progression of human
cutaneous melanoma is associated with loss of expression of c-kit
proto-oncogene receptor. Int J Cancer. 52:197–201. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Berdel WE, De Vos S, Maurer J, Oberberg D,
von Marschall Z, Schroeder JK, Li J, Ludwig WD, Kreuser ED, Thiel
E, et al: Recombinant human stem cell factor stimulates growth of a
human glioblastoma cell line expressing c-kit protooncogene. Cancer
Res. 52:3498–3502. 1992.PubMed/NCBI
|
|
16
|
Natali PG, Nicotra MR, Sures I, Mottolese
M, Botti C and Ullrich A: Breast cancer is associated with loss of
the c-kit oncogene product. Int J Cancer. 52:713–717. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hida T, Ueda R, Sekido Y, Hibi K, Matsuda
R, Ariyoshi Y, Sugiura T and Takahashi T and Takahashi T: Ectopic
expression of c-kit in small-cell lung cancer. Int J Cancer Suppl.
8:108–109. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hines SJ, Organ C, Kornstein MJ and
Krystal GW: Coexpression of the c-kit and stem cell factor genes in
breast carcinomas. Cell Growth Differ. 6:769–779. 1995.PubMed/NCBI
|
|
19
|
Bokemeyer C, Kuczyk MA, Dunn T, Serth J,
Hartmann K, Jonasson J, Pietsch T, Jonas U and Schmoll HJ:
Expression of stem-cell factor and its receptor c-kit protein in
normal testicular tissue and malignant germ-cell tumours. J Cancer
Res Clin Oncol. 122:301–306. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Krystal GW, Hines SJ and Organ CP:
Autocrine growth of small cell lung cancer mediated by coexpression
of c-kit and stem cell factor. Cancer Res. 56:370–376.
1996.PubMed/NCBI
|
|
21
|
Montone KT, van Belle P, Elenitsas R and
Elder DE: Protooncogene c-kit expression in malignant melanoma:
Protein loss with tumor progression. Mod Pathol. 10:939–944.
1997.PubMed/NCBI
|
|
22
|
Tian Q, Frierson HF Jr, Krystal GW and
Moskaluk CA: Activating c-kit gene mutations in human germ cell
tumors. Am J Pathol. 154:1643–1647. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Feng F, Liu XH, Xie Q, Liu WQ, Bai CG and
Ma DL: Expression and mutation of c-kit gene in gastrointestinal
stromal tumors. World J Gastroenterol. 9:2548–2451. 2003.PubMed/NCBI
|
|
24
|
Bellone G, Smirne C, Carbone A, Buffolino
A, Scirelli T, Prati A, Solerio D, Pirisi M, Valente G, Nano M and
Emanuelli G: KIT/stem cell factor expression in premalignant and
malignant lesions of the colon mucosa in relationship to disease
progression and outcomes. Int J Oncol. 29:851–859. 2006.PubMed/NCBI
|
|
25
|
Quinlan RA, Schiller DL, Hatzfeld M,
Achtstätter T, Moll R, Jorcano JL, Magin TM and Franke WW: Patterns
of expression and organization of cytokeratin intermediate
filaments. Ann N Y Acad Sci. 455:282–306. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moll R, Schiller DL and Franke WW:
Identification of protein IT of the intestinal cytoskeleton as a
novel type I cytokeratin with unusual properties and expression
patterns. J Cell Biol. 111:567–580. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamagishi H, Imai Y, Okamura T, Fukuda K,
Ono Y, Ban S, Inoue T and Ueda Y: Aberrant cytokeratin expression
as a possible prognostic predictor in poorly differentiated
colorectal carcinoma. J Gastroenterol Hepatol. 28:1815–1822. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Varadhachary GR, Abbruzzese JL and Lenzi
R: Diagnostic strategies for unknown primary cancer. Cancer.
100:1776–1785. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kirchner T, Müller S, Hattori T, Mukaisyo
K, Papadopoulos T, Brabletz T and Jung A: Metaplasia,
intraepithelial neoplasia and early cancer of the stomach are
related to dedifferentiated epithelial cells defined by
cytokeratin-7 expression in gastritis. Virchows Arch. 439:512–522.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Slaughter DP, Southwick HW and Smejkal W:
Field cancerization in oral stratified squamous epithelium;
clinical implications of multicentric origin. Cancer. 6:963–968.
1953. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Luo Y, Yu M and Grady WM: Field
cancerization in the colon: A role for aberrant DNA methylation?
Gastroenterol Rep (Oxf). 2:16–20. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lyda MH, Noffsinger A, Belli J and
Fenoglio-Preiser CM: Microsatellite instability and K-ras mutations
in patients with ulcerative colitis. Hum Pathol. 31:665–671. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Leedham SJ, Graham TA, Oukrif D, McDonald
SA, Rodriguez-Justo M, Harrison RF, Shepherd NA, Novelli MR,
Jankowski JA and Wright NA: Clonality, founder mutations, and field
cancerization in human ulcerative colitis-associated neoplasia.
Gastroenterology. 136:542–550.e6. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Koizumi K, Alonso S, Miyaki Y, Okada S,
Ogura H, Shiiya N, Konishi F, Taya T, Perucho M and Suzuki K:
Array-based identification of common DNA methylation alterations in
ulcerative colitis. Int J Oncol. 40:983–994. 2011.PubMed/NCBI
|
|
35
|
Galandiuk S, Rodriguez-Justo M, Jeffery R,
Nicholson AM, Cheng Y, Oukrif D, Elia G, Leedham SJ, McDonald SA,
Wright NA and Graham TA: Field cancerization in the intestinal
epithelium of patients with Crohn's ileocolitis. Gastroenterology.
142:855–864.e8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lochhead P, Chan AT, Nishihara R, Fuchs
CS, Beck AH, Giovannucci E and Ogino S: Etiologic field effect:
Reappraisal of the field effect concept in cancer predisposition
and progression. Mod Pathol. 28:14–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Facista A, Nguyen H, Lewis C, Prasad AR,
Ramsey L, Zaitlin B, Nfonsam V, Krouse RS, Bernstein H, Payne CM,
et al: Deficient expression of DNA repair enzymes in early
progression to sporadic colon cancer. Genome Integr. 3:32012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Harbaum L, Pollheimer MJ, Kornprat P,
Lindtner RA, Schlemmer A, Rehak P and Langner C: Keratin 7
expression in colorectal cancer-freak of nature or significant
finding? Histopathology. 59:225–234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Park SY, Kim HS, Hong EK and Kim WH:
Expression of cytokeratins 7 and 20 in primary carcinomas of the
stomach and colorectum and their value in the differential
diagnosis of metastatic carcinomas to the ovary. Hum Pathol.
33:1078–1085. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Besmer P, Murphy JE, George PC, Qiu FH,
Bergold PJ, Lederman L, Snyder HW Jr, Brodeur D, Zuckerman EE and
Hardy WD: A new acute transforming feline retrovirus and
relationship of its oncogene v-kit with the protein kinase gene
family. Nature. 320:415–421. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yarden Y, Kuang WJ, Yang-Feng T, Coussens
L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U and
Ullrich A: Human proto-oncogene c-kit: A new cell surface receptor
tyrosine kinase for an unidentified ligand. EMBO J. 6:3341–3351.
1986.
|
|
42
|
Ashman LK: The biology of stem cell factor
and its receptor C-kit. Int J Biochem Cell Biol. 31:1037–1051.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rönnstrand L: Signal transduction via the
stem cell factor receptor/c-Kit. Cell Mol Life Sci. 61:2535–2548.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Preto A, Moutinho C, Velho S, Oliveira C,
Rebocho AP, Figueiredo J, Soares P, Lopes JM and Seruca R: A subset
of colorectal carcinomas express c-KIT protein independently of
BRAF and/or KRAS activation. Virchows Arch. 450:619–626. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sammarco I, Capurso G, Coppola L, Bonifazi
AP, Cassetta S, Fave G Delle, Carrara A, Grassi GB, Rossi P, Sette
C and Geremia R: Expression of the protooncogene c-KIT in normal
and tumor tissues from colorectal carcinoma patients. Int J
Colorectal Dis. 19:545–553. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Friederichs J, von Weyhern CW, Rosenberg
R, Doll D, Busch R, Lordick F, Siewert JR and Sarbia M:
Immunohistochemical detection of receptor tyrosine kinases c-kit,
EGF-R, and PDGF-R in colorectal adenocarcinomas. Langenbecks Arch
Surg. 395:373–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Reed J, Ouban A, Schickor FK, Muraca P,
Yeatman T and Coppola D: Immunohistochemical staining for c-Kit
(CD117) is a rare event in human colorectal carcinoma. Clin
Colorectal Cancer. 2:119–122. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Medinger M, Kleinschmidt M, Mross K,
Wehmeyer B, Unger C, Schaefer HE, Weber R and Azemar M: c-kit
(CD117) expression in human tumors and its prognostic value: An
immunohistochemical analysis. Pathol Oncol Res. 16:295–301. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Toyota M, Hinoda Y, Takaoka A, Makiguchi
Y, Takahashi T, Itoh F, Imai K and Yachi A: Expression of c-kit and
kit ligand in human colon carcinoma cells. Tumour Biol. 14:295–302.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lahm H, Amstad P, Yilmaz A, Borbenyi Z,
Wyniger J, Fischer JR, Suardet L, Givel JC and Odartchenko N:
Interleukin 4 down-regulates expression of c-kit and autocrine stem
cell factor in human colorectal carcinoma cells. Cell Growth
Differ. 6:1111–1118. 1995.PubMed/NCBI
|
|
51
|
Kitamura T, Kometani K, Hashida H,
Matsunaga A, Miyoshi H, Hosogi H, Aoki M, Oshima M, Hattori M,
Takabayashi A, et al: SMAD4-deficient interstinal tumors recruit
CCR1+ myeloid cells that promote invasion. Nat Genet. 39:467–475.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kitamura T, Fujishita T, Loetscher P,
Revesz L, Hashida H, Kizaka-Kondoh S, Aoki M and Taketo MM:
Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses
colon cancer liver metastasis by blocking accumulation of immature
myeloid cells in a mouse model. Proc Natl Acad Sci USA. 107:pp.
13063–13068. 2010; View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yilmaz E, Celik O, Simsek Y, Turkcuoglu I,
Celik E, Gül M, Hascalik S and Aydin NE: c-Kit proto-oncogene
expression in endometrial hyperplasia and endometrial cancer. Arch
Gynecol Obstet. 286:197–200. 2012. View Article : Google Scholar : PubMed/NCBI
|
